ArticleInternational journal of clinical and experimental pathology2015

MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.

Hesheng Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.